The choice of therapy depends on multiple factors, including medical history, side effect profile, convenience, cost, and personal preferences
Table 2 below depicts Medicare Part Ds national gross spending on GLP-1s that are FDA-approved for treating T2D
Abboud KY, Reis SK, Martelli ME, et al
Not every patient needs this, but for patients with significant muscle mass concerns older adults, perimenopausal women, patients losing weight quickly at high doses it is worth considering
after getting FDA approval in 2022
Considerations Supporting Elevate Health: Cost accessibility - At $114-$263/month with payment plan options, Elevate Health's pricing is substantially lower than the $1,000+ monthly cost of brand-name Wegovy or Zepbound without insurance